tradingkey.logo

Can Fite Biopharma Ltd

CANF
View Detailed Chart

0.715USD

+0.013+1.88%
Close 07/29, 16:00ETQuotes delayed by 15 min
2.13BMarket Cap
LossP/E TTM

Can Fite Biopharma Ltd

0.715

+0.013+1.88%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.88%

5 Days

-30.28%

1 Month

-31.29%

6 Months

-53.29%

Year to Date

-56.02%

1 Year

-77.81%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts
BUY
Current Rating
10.833
Target Price
1444.53%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

172
Total
5
Median
8
Average
Company name
Ratings
Analysts
Can Fite Biopharma Ltd
CANF
2
Biogen Inc
BIIB
37
Vertex Pharmaceuticals Inc
VRTX
34
Alnylam Pharmaceuticals Inc
ALNY
33
Amgen Inc
AMGN
33
Gilead Sciences Inc
GILD
30
1
2
3
...
35

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(8)
Neutral(0)
Buy(0)
Indicators
Sell(2)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.062
Sell
RSI(14)
14.264
Oversold
STOCH(KDJ)(9,3,3)
12.376
Oversold
ATR(14)
0.047
High Vlolatility
CCI(14)
-275.786
Oversold
Williams %R
89.139
Oversold
TRIX(12,20)
-0.441
Sell
StochRSI(14)
7.525
Oversold
Moving Average
Sell(6)
Neutral(0)
Buy(0)
Indicators
Value
Direction
MA5
0.888
Sell
MA10
0.962
Sell
MA20
0.997
Sell
MA50
1.040
Sell
MA100
1.199
Sell
MA200
1.524
Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Can Fite Biopharma Ltd is an Israel-based clinical-stage biopharmaceutical company engaged in developing orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The Company co-develop formulations of cannabis components for the treatment of cancer, inflammatory, autoimmune, and metabolic diseases. Its technology utilizes the Gi protein associated A3AR as a therapeutic target. A3AR is expressed in inflammatory and cancer cells, and not significantly expressed in normal cells, suggesting that the receptor could be a target for pharmacological intervention.
Ticker SymbolCANF
CompanyCan Fite Biopharma Ltd
CEODr. Pnina Fishman, Ph.D.
Websitehttps://www.canfite.com/
KeyAI